Events Archives - Page 113 of 128

1 minute read

Events
News

Stevanato Group to Present Recent Developments in Its Integrated Product and Service Offering at Four Major Pharmaceutical Industry Trade Shows Between the U.s. And Europe

September 30, 7:51 AM

Stevanato Group S.p.A. (NYSE: STVN) will be exhibiting at four major international trade shows during the fall season to present its products and services for CMOs, CDMOs and pharma companies.

STVN

4 minute read

Tesla AI Day 2022 Is Here: Updates On Optimus, Dojo, FSD And What Else To Expect Tonight

By Shanthi Rexaline

September 30, 6:18 AM

Tesla Inc. (NASDAQ: TSLA) CEO Elon Musk and his team are gearing up to host the company’s second AI Day.

ABNB

3 minute read

Amazon Introduces Bedside Sleep Tracker, First Kindle That Can Write And More: What You Need To Know

By Anusuya Lahiri

September 28, 1:47 PM

AMZN

4 minute read

Events
News

Wave Life Sciences Highlights Therapeutic Potential For WVE-006 For Alpha-1 Antitrypsin Deficiency And Progress Bringing RNA Editing To The Clinic During Analyst And Investor Event

By Benzinga Newsdesk

September 28, 1:31 PM

WVE-006 is the most advanced candidate for AATD designed to restore functional wild-type AAT protein and reduce Z-AAT protein aggregation with potential for disease modification in both lung and liver

WVE

2 minute read

With Hurricane Ian About To Slam Florida, Which Insurance, Bank Stocks Are Most Exposed?

By Wayne Duggan

September 28, 1:09 PM

Hurricane Ian is just off the Gulf Coast of Florida and approaching landfall near Cape Coral as a Category 4 storm with maximum sustained winds of 155 miles per hour.

ACGL

1 minute read

Tiziana Life Sciences Announced Presentations on Intranasal Foralumab at the “Preserving the Brain” Scientific Conference and Exhibit at the Fondazione Prada in Milan

By Charles Gross

September 28, 7:22 AM

Tiziana Life Sciences Ltd. (Nasdaq: TLSA) today announced that poster presentations on intranasal foralumab were presented at the "Preserving the Brain" scientific conference and exhibit held at the Fondazione Prada in Milan, Italy.

TLSA

3 minute read

ASLAN Pharmaceuticals Presents New Data on Eblasakimab in Two Late-Breaking e-Posters at the 51st Annual European Society for Dermatological Research Meeting

By Charles Gross

September 28, 7:18 AM

ASLAN Pharmaceuticals (NASDAQ: ASLN) today announced the presentation of new translational eblasakimab data at the 51st Annual European Society for Dermatological Research (ESDR) Meeting.

ASLN